In May 2023, the FDA included both Ozempic and Mounjaro on its shortages list, legalizing compounded versions of the drugs
Symptoms of electrolyte imbalance, dizziness, muscle cramps, heart palpitations, and weakness, overlap with tirzepatide side effects, making them easy to miss
Molecular Formula: C35H48N10O15 Amino Acid Sequence: H-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu-OH Molecular Weight: 848.8 g/mol View the HPLC Certificate here
Its effects on melanocortin pathways also provide insight into appetite regulation and energy homeostasis, making it relevant for broader peptide research
The FDA approved Ozempic in December 2017 for type 2 diabetes treatment, but the agency didnt add ileus warnings to the label until September 2023 nearly six years after approval